See also this year's filing and all EDGAR filings for this company.
PDF Report 0001096294_2013_GFR_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001096294, GFR Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,434,609 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 9,586,648 |
| 3 | remainder_Assets | 1,145,107 |
| 4 | LiabilitiesCurrent | 739,531 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 849,550 |
| 7 | CostOfGoodsAndServicesSold | 1,498,318 |
| 8 | SellingGeneralAndAdministrativeExpense | 786,031 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 654,378 |
| 11 | remainder_Revenues | 4,271,794 |
| 12 | remainder_NetIncome | 2,013 |
| 13 | remainder_ComprehensiveNetIncome | -22,489 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 12,166,364 |
| 1 | Liabilities | 1,589,081 |
| 2 | Expenses | 2,938,727 |
| 3 | Revenues | 4,271,794 |
| 4 | StockholdersEquity | 10,577,283 |
| 5 | NetIncome | 1,335,080 |
| 6 | ComprehensiveNetIncome | 1,323,836 |
| 7 | BaseVar | 10,495,234 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.55 |
| 9 | EconomicCapitalRatio | 4.06 |
Edgar->Model Mapping
Feature Distribution
Change over Time
